Skip to main content
SpringerLink
Log in

How can we tell if a treatment works? Further thoughts on the randomized controlled trial

  • Guest Editorial
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rose GA. The study of osteoporosis and osteomalacia. Postgrad Med J 1964; 40:158–63.

    Article  CAS  PubMed  Google Scholar 

  2. Mosekilde L. Age-related changes in vertebral trabecular bone architecture-assessed by a new method. Bone 1988; 9:247–50.

    Article  CAS  PubMed  Google Scholar 

  3. Rich C, Bernstein DS, Gates S et al. Factors involved in an objective study of the efficacy of treatment of osteoporosis. Clin Orthop 1966; 45:63–6.

    CAS  PubMed  Google Scholar 

  4. Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322:802–9.

    CAS  PubMed  Google Scholar 

  5. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent, cycLJcal etidronate therapy on bone mass and fracture rate in postmenopausal osteoporosis. N Engl J Med 1990; 322:1265–71.

    CAS  PubMed  Google Scholar 

  6. Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323:73–9.

    CAS  PubMed  Google Scholar 

  7. Wolf S. The pharmacology of placebos. Pharmacol Rev 1959; 11:689–704.

    CAS  PubMed  Google Scholar 

  8. Beecher HK. The powerful placebo. JAMA 1955; 159:1602–6.

    CAS  Google Scholar 

  9. Goodwin JS, Goodwin JM, Vogel AV. Knowledge and use o placebos by house officers and nurses. Ann Intern Med 1979; 91:106–10.

    CAS  PubMed  Google Scholar 

  10. Heaney RP. How do we know what we know? The randomized controlled trial revisited. J Bone Miner Res 1991; 6:103–5.

    Article  CAS  PubMed  Google Scholar 

  11. Feinstein AR. Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. J Clin Epidemiol 1989; 42:481–9.

    Article  CAS  PubMed  Google Scholar 

  12. Korn EL, Baumrind S. Randomized cLJnical trials with clinician-preferred treatment. Lancet 1991; 337:149–52.

    Article  CAS  PubMed  Google Scholar 

  13. Veatch RM. Justice and research design: the case for a semirandomization clinical trial. Clin Res 1983; 31:12–22.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Creighton University, California at 24th Street, 68178-0650, Omaha, Nebraska, USA

    R. P. Heaney

Authors
  1. R. P. Heaney
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heaney, R.P. How can we tell if a treatment works? Further thoughts on the randomized controlled trial. Osteoporosis Int 1, 215–217 (1991). https://doi.org/10.1007/BF03187465

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03187465

Search

Navigation